← Funding directory

Dated funding evidence

Ultraleap

Series D · £60M (~$82M) · 2021-11-17

Reported round£60M (~$82M)Series D
Disclosure date
2021-11-17
Reported currency
GBP
Companies House
08781720
Evidence sources
2

Company

UltraleapCH 08781720
2021-11-17Series D£60M (~$82M)

Resolved investor records

Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.

SourceVC research snapshot; Live Chris T D1Date2021-11-17Matchfunding_id joined to resolved canonical companyStatepublished

Record fields

What the source states

Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.

Round ID
FR-00679
Stage
Series D
Round name
Series D
Amount
£60M (~$82M)
Lead investors
Not stated
Other investors
Tencent, British Patient Capital, CMB International, Mayfair Equity Partners, IP Group
Source layers
VC research snapshot, Live Chris T D1
Snapshot
2026-08-15

Named evidence

Source trail

This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.

A 37X Ventures portfolio site

Operated by 37x Limited, a Guernsey Non Cellular Company, company number CMP76157, incorporated 18 July 2025.

Registered office: Les Echelons Court, Les Echelons, St. Peter Port, Guernsey, GY1 1AR.

Full company details